1. Clinical Overview
A triple-drug, fixed-dose combination (FDC) antihypertensive therapy that provides synergistic blood pressure control through complementary mechanisms: Angiotensin II Receptor Blockade (ARB), dual L/N-type Calcium Channel Blockade (CCB), and Thiazide-like Diuresis. This combination is particularly effective for moderate to severe hypertension and is designed to improve adherence by reducing pill burden. It is a rational combination as per Indian Hypertension Guidelines (ISH 2020, API 2022) for patients requiring more than two drugs.
| Onset | Duration | Bioavailability |
|---|---|---|
| Olmesartan: 1-2 hours; Cilnidipine: 1-2 hours; Chlorthalidone: 2-6 hours. | Olmesartan: >24 hours; Cilnidipine: 24 hours; Chlorthalidone: 24-72 hours. | Olmesartan Medoxomil: ~26%; Cilnidipine: ~90%; Chlorthalidone: ~65%. |
2. Mechanism of Action
This combination exerts a multi-pronged attack on hypertension: 1) Olmesartan blocks the binding of angiotensin II to the AT1 receptor, preventing vasoconstriction, aldosterone secretion, and sodium retention. 2) Cilnidipine blocks L-type calcium channels in vascular smooth muscle (vasodilation) and N-type channels in sympathetic nerve terminals (inhibits norepinephrine release, reducing sympathetic tone). 3) Chlorthalidone inhibits sodium-chloride symporter in the distal convoluted tubule, promoting natriuresis and diuresis, reducing plasma volume.
3. Indications & Uses
- Essential Hypertension (Stage 2 or uncontrolled on dual therapy)
- Hypertension requiring more than two drugs for control as per Indian guidelines
4. Dosage & Administration
Adult Dosage: One tablet once daily, preferably in the morning. Dose can be taken with or without food.
Administration: Swallow whole with a glass of water. Do not crush or chew. Can be taken with food to minimize potential gastric upset from cilnidipine. Maintain adequate fluid intake unless contraindicated. Missed dose: Take as soon as remembered, but skip if it's almost time for the next dose. Do not double dose.
5. Side Effects
Common side effects may include:
- Dizziness/lightheadedness
- Headache
- Peripheral edema (less with cilnidipine than amlodipine)
- Fatigue/asthenia
- Nausea
- Increased urination (initial phase)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Antihypertensives (ACEi, Beta-blockers, Alpha-blockers) | Additive hypotensive effect, risk of severe hypotension. | Major |
| Potassium supplements / Potassium-sparing diuretics (Spironolactone, Amiloride) / Salt substitutes | Increased risk of hyperkalemia, especially with olmesartan. | Major |
| NSAIDs (e.g., Ibuprofen, Diclofenac, Naproxen) | Reduced antihypertensive effect; increased risk of renal impairment and hyperkalemia. | Major |
| Lithium | Chlorthalidone reduces renal clearance of lithium, leading to toxicity. | Major |
| Digoxin | Hypokalemia from chlorthalidone can potentiate digoxin toxicity. | Moderate |
| CYP3A4 Inhibitors (Ketoconazole, Itraconazole, Clarithromycin, Ritonavir) | Increase cilnidipine levels, risk of hypotension and edema. | Moderate |
| CYP3A4 Inducers (Rifampicin, Phenytoin, Carbamazepine) | Decrease cilnidipine levels, reducing efficacy. | Moderate |
| Corticosteroids | Antagonize hypokalemic and hypotensive effects. | Moderate |
| Allopurinol | Increased risk of hypersensitivity reactions with chlorthalidone. | Moderate |
| Antidiabetic drugs (Insulin, Sulfonylureas) | Chlorthalidone may impair glucose tolerance, requiring dose adjustment. | Moderate |
7. Patient Counselling
- DO take the medicine at the same time every day, preferably in the morning.
- DO monitor your blood pressure regularly as advised by your doctor.
- DO maintain adequate hydration unless advised otherwise.
- DO inform all your doctors and dentists about all medicines you are taking.
- DONT stop taking this medicine suddenly even if you feel well; hypertension is often asymptomatic.
- DONT take over-the-counter painkillers (NSAIDs like ibuprofen) without consulting your doctor.
- DONT use potassium supplements or salt substitutes without medical advice.
- DONT become pregnant while on this medication; use effective contraception.
8. Toxicology & Storage
Overdose: Manifestations are primarily due to pharmacodynamic effects: Profound hypotension, tachycardia (or bradycardia depending on cilnidipine's dual effect), dizziness, syncope, electrolyte disturbances (hypokalemia, hyponatremia), dehydration, and acute renal failure secondary to hypoperfusion.
Storage: Store below 30°C. Protect from light and moisture. Keep the blister strips/container tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.